What is the outcome of the legal dispute between Masimo and Apple?

Apple has been ordered to pay $634 million to Masimo for infringing on the company's patent related to blood oxygen monitoring technology used in the Apple Watch.

How did the U.S. International Trade Commission rule in the Masimo vs. Apple case?

The ITC sided with Masimo in 2023, banning the import of Apple Watches with blood oxygen monitoring features.

What is Masimo's stance on protecting its intellectual property?

Masimo has stated that this verdict is a significant win in its ongoing efforts to protect its innovations and intellectual property, which is crucial to its ability to develop technology that benefits patients.

Home / Technology / Apple Ordered to Pay $634M for Infringing Masimo's Blood Oxygen Patent

Apple Ordered to Pay $634M for Infringing Masimo's Blood Oxygen Patent

16 Nov

•

Summary

Federal jury rules Apple must pay $634M to Masimo for patent infringement
Apple's Apple Watch features violated Masimo's blood oxygen monitoring patent
Masimo committed to defending its intellectual property rights

Apple Ordered to Pay $634M for Infringing Masimo's Blood Oxygen Patent

In a significant legal development, a federal jury in California has ordered tech giant Apple to pay $634 million to medical device manufacturer Masimo. The jury found that Apple's Apple Watch features, including the workout mode and heart rate notification functions, had infringed on a Masimo patent related to blood oxygen monitoring technology.

Masimo, a leading provider of innovative medical devices, has hailed this verdict as a crucial win in its ongoing efforts to safeguard its intellectual property and innovations. The company stated that protecting its patents is essential to its ability to develop cutting-edge technologies that benefit patients.

However, Apple has vowed to appeal the decision, arguing that the patent in question expired in 2022 and is specific to outdated patient monitoring technology from decades ago. The tech giant maintains that it plans to continue defending its position and fighting the ruling.